






























































































This! research! has! been! funded! by! the! National! Institute! for! Health! Research,!
including!through!a!Doctoral!Research!Fellowship.!
!
I!would! like! to!acknowledge! the!role!of!both!Professor!T!Solomon!and!Professor!R!
Borrow!who!supervised!this!PhD.! I!would! like!to!thank!Professor!T!Solomon!for!his!







I! would! like! to! acknowledge! those! who! supported! specific! aspects! of! the! work!
included!in!this!thesis:!
!
Chapter! 2:! I! would! like! to! thank! Professor! Scott! Letendre! and! colleagues! at! the!
Human!Immunodeficiency!Virus!Neurobehavioural!Research!Programme,!and!more!
broadly! the! Central! Nervous! System! HIV! AntiSretroviral! Therapy! Effects! Research!
study!group,!for!their!collaboration!on!the!preliminary!work!on!patients!with!chronic!
inflammation! in! relation! to! viral! infection.! I!would! also! like! to! thank!Dr!Anu! Jacob!





Chapter! 3:! I! would! like! to! thank! Dr! Rachel! Kneen! who! supported! the! national!
surveillance! study,! in! addition! to! Dr! Anu! Goenka! and! colleagues! from! the! British!
Adult!and!Paediatric!Neurological!Surveillance!Units!with!whom!the!published!paper!




of! Liverpool! helped! me! develop! some! of! the! technical! aspects! of! the! application!
ClickClinica!©,!and!I!am!very!thankful!for!this!assistance!and!as!a!coSauthor!on!the!







































































































































































































































































































































































































































































Clinical syndrome of altered mental status (manifesting as reduced consciousness or altered 
cognition, personality, or behaviour) 
 
 Has many causes including systemic infection, metabolic encephalopathies, toxins, hypoxia, 




Inflammation of the brain 
  
Strictly a pathological diagnosis; but surrogate clinical markers often used, including 
inflammatory change in the cerebrospinal fluid or parenchymal inflammation on imaging 
 
 Causes include viruses, small intracellular bacteria that directly infection the brain parenchyma 
and some parasites 
 
Can also occur without direct brain infection, for example in acute disseminated 


































Groups Viruses Comments 
   
Sporadic causes (not geographically restricted) listed by group 
   
Herpes viruses (family Herpesviridae)  
 Herpes simplex virus type 1 Most commonly diagnosed sporadic encephalitis 
 Herpes simplex virus type 2 Causes meningitis in adults (esp. recurrent); Meningoencephalitis occurs typically in the 
immunocompromised. Also causes a radiculitis. 
 Varicella zoster virus  Post-infective cerebellitis, or acute infective encephalitis or vasculopathy 
 Epstein-Barr virus Encephalitis in the immunocompromised 
 Cytomegalovirus Encephalitis in the immunocompromised; also retinitis or radiculitis; often neutrophilic CSF with low 
glucose 
 Human herpes virus 6 & 7 Febrile convulsions in children (after roseola); encephalitis in immunocompromised 
Enteroviruses (family Picornaviridae)  
 Enterovirus 70 Epidemic haemorrhagic conjunctivitis, with CNS involvement 
 Enterovirus 71 Epidemic hand foot and mouth disease, with aseptic meningitis, brainstem encephalitis, myelitis 
 Poliovirus Myelitis 
 Coxsackieviruses, Echoviruses,  
Parechovirus 
Mostly aseptic meningitis 
Paramyxoviruses (family Paramyxoviridae)  
 Measles virus Causes acute post-infectious encephalitis, subacute encephalitis and subacute sclerosing 
panencephalitis 
 Mumps virus Parotitis, orchitis or pancreatitis may occur before, during or after meningoencephalitis 
Others (rarer causes)  
 Influenza viruses, adenovirus, 
parvovirus B19, lymphocytic 





Arthropod-borne and zoonotic viruses*  
    
Flaviviruses (family Flaviviridae)  
 West Nile virus North America, Southern Europe, Africa, Middle East, West and Central Asia associated with flaccid 
paralysis and Parkinsonian movement disorders 






 Tick-borne encephalitis virus Travel in Eastern Europe, Former USSR; tick bite; upper limb flaccid paralysis 
 Dengue viruses (types 1-4) Causes fever, arthralgia, rash and haemorrhagic disease, occasional CNS disease  
Alphaviruses (family Togaviridae)  
 Western, Eastern and Venezuelan 
equine encephalitis viruses 
Found in the Americas; encephalitis of horses and humans 
 Chikungunya virus Asia Pacific, Africa 
Bunyaviruses  
 Lacrosse virus Encephalitis in America 
Coltiviruses   
 Colorado tick fever virus North America 
Rhabdoviruses  
 Rabies, virus other lyssaviruses Non-arthropod-borne zoonitic viruses transmitted by dogs, cats, bats, depending on location 
 Chandipura virus Transmitted by sandflies, causing outbreaks in India 
Henipah Viruses   
 Nipah virus Transmitted in faeces of fruit bats in Malaysia, Bangladesh 
      
   
Note viral causes of chronic encephalitis such as JC viruses are not included here 
*Most are zoonotic - i.e. animals rather than humans are the main natural hosts, the exceptions being dengue and chikungunya viruses 
 




            
      
   ENCEPHALITIS  MIMICS 
      
CNS INFECTIONS   
      
Bacteria    
  Small bacteria (mostly intracellular)   
   Mycoplasma pneumoniae   Mycobacterium tuberculosis 
   Chlamydophila   Streptococcus pneumoniae 
   Rickettsiae (including scrub typhus, Rocky Mountain spotted fever)  Haemophilus influenza 
   Ehrlichiosis (anaplasmosis)  Neisseria meningitidis 
   Coxiella burnetti (Q fever)   
   Bartonella hensellae (cat scratch fever)  Salmonella typhi 
   Tropherema whipplei (Whipple's disease)    
   Brucella (Brucellosis) 
Listeria monocytogenes 
  
      
  Spirochetes   
   Trepenoma pallidum (Syphilis)  Leptospira 
   Borrelia burgdorferi (Lyme neuroborreliosis)   
   Borrelia recurrentis (relapsing fever)   
      
  Other bacteria   
   Nocardiosis  Sub-acute bacterial endocarditis 
   Actinomycosis  Parameningeal infection 
     Abscess / empyema 
      
      
Parasites    
   Trypanosoma brucei gambiense and Trypanosoma 
brucei rhodesiense  (sleeping sickness) 
 Malaria 
   Naegleria fowleri, Balamuthia mandrellis (Amoebic 
encephalitis) 
 Cysticercosis 
   Angiostrongylus cantonensis (rat lung worm)   
     Trichinosis 
      
Fungi    
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   Coccidiomycosis  Cryptococcosis 
   Histoplasmosis   
   North American blastomycosis   
    
 
  
PARA/POST INFECTIOUS CAUSES   
      
  Inflammatory   
   Acute disseminated encephalomyelitis (ADEM)   
   Acute haemorrhagic leukoencephalopathy (AHLE) 
Acute necrotising encephalitis (ANE) in children 
  
   Bickerstaff's encephalitis   
      
  Toxic / Metabolic   
     Reye’s syndrome 
      
  Systemic infection   
     Septic encephalopathy 
     Shigellosis 
      
      
      
NON-INFECTIOUS CAUSES   
      
  Vascular   
     Vasculitis 
     Systemic lupus erythematosis 
     Behcet's disease 
     Subarachnoid & subdural haemorrhage 
     Ischaemic cerebrovascular accidents 
  Neoplastic   
   Paraneoplastic encephalitis  Primary brain tumour 
     Metastases 
      
  Metabolic encephalopathy   
     Hepatic encephalopathy 
     Renal encephalopathy 
     Hypoglycaemia 
     Toxins (alcohol, drugs) 
     Hashimoto's disease 
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     Septic encephalopathy 
     Mitochondrial diseases 
  Other   
   Antibody-associated encephalitis: VGKC complex or NMDA receptor  Drug reactions 
   Encephalitis lethargica 
Haemophagocytic Lymphohistiocytosis (HLH) usually 
children 
 Epilepsy 
     Functional disorder 
            
      
* Almost every infectious and non-infectious condition can occasionally present with an encephalitis-like illness. 
   In this table some of the important aetiologies are classified into whether they cause an encephalitis, with inflammatory changes seen histopathologically in the brain      
   parenchyma, or encephalopathy without inflammatory changes in the parenchyma, although for some aetiologies this is based on limited evidence 
 

































































































































































































































































- Vesicle (if present)
Sputum (if symptoms)
Urine (if mumps)
- 3x thick/thin malaria films
- Rapid malaria antigen test
- CSF flavivirus igM
If positive:
- CSF PCR for EBV + CMV
- CSF TB staining + culture
- CSF + blood culture for 
  Listeria monocytogenes
- CSF india ink staining +/or
  cryptococcal antigen for
  Cryptoccus neoformans
- CSF PCR + serology for
  Toxoplasma gondii
- CSF + serum antibody for
  syphilis
Consider: 
- CSF PCR for HHV6 + 7
- CSF PCR for JC/BK virus
- CSF for Coccidioides +
  Histoplasma
(on first LP)
- Repeat CSF PCR on 2nd LP
- Consider HSV CSF IgG at
  10-14 days
- If subtle motor status
  epilepticus suspected
- If unclear if psychiatric





Clinical features suspicious of
Encephalitis















Opening pressure: CSF and serum glucose: CSF
Protein: 2x MC&S: virology PCR: lactate:









































(adjust for renal failure)
Given 8 hourly:
Neonate-3 months: 20mg/kg







}Tables associated with this algorithm are on the next page.
Patients (when conscious level permits) and their next-of-kin should be made aware of the support provided by voluntary 
sector partners such as the Encephalitis Society (www.Encephalitis.info)
KEY:
CT (Computed tomography [brain scan])
CSF  (Cerebrospinal fluid) 
PCR  (Polymerase chain reaction [virus detection])
GCS  (Glasgow coma score) on the next page
ABCD  (Airways, Breathing, Circulation and Disability)
ICU  (Intensive Care Unit)
LP (Lumbar Puncture)
IV  (Intravenous)
MC&S (Microscopy, Culture and Sensitivity)
MRI (Magnetic Resonance Imaging)
HSV  (Herpes Simplex Virus)
VZV (Varicella Zoster Virus)





































































































































































































































































































































































































































































































































































































































































































































































































2.4 Ethical Approval 
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The$ most$ common$ sporadic$ cause$ of$ encephalitis$ is$ HSV$ type$ 1,$ representing$ an$
uncommon$complication$of$a$common$infection$(Granerod$et$al$2010).$Whilst$globally$
acute$ viral$ encephalitis$ is$ often$ due$ to$ epidemic$ pathogens,$ such$ as$ Japanese$
encephalitis$ virus,$ the$ epidemiology$ of$ encephalitis$ in$ relation$ to$ a$ pandemic$ viral$
infection$is$poorly$understood,$particularly$in$the$UK$(Surana$et$al$2011).$
$
The$ emergence$ of$ novel$ influenza$ A:H1N1$ in$ 2009$ was$ associated$ with$ the$
appearance$of$case$reports$and$series$describing$related$neurological$manifestations$
(Centers$for$Disease$Control$and$Prevention$2009;$Ekstrand$et$al$2010;$Farooq$et$al$












Australia,$ between$ 6<19%$ of$ children$ hospitalised$ with$ influenza$ infection$ have$
neurological$manifestations$(Ekstrand$et$al$2010;$Farooq$et$al$2012;$Khandaker$et$al$
2012).$ With$ the$ increasing$ availability$ of$ MRI$ and$ newer$ imaging$ modalities,$ the$
generic$term$“influenza<related$encephalopathy/encephalitis”$has$been$sub<classified$
into$a$range$of$specific$acute$encephalopathy$syndromes$[AES]$e.g.$acute$necrotizing$
encephalopathy$ [ANE]$ (Mizuguchi$ et$ al$1995;$Akins$ et$ al$2010).$ Fewer$ specific$AES$
have$ been$ described$ in$ adults$ but$ acute$ haemorrhagic$ leukoencephalopathy$ [AHL]$
appears$ to$ be$ important$ (Cisse$ et$ al$ 2010).$ Identification$ and$ description$ of$ AES$ is$
useful$to$help$predict$the$prognosis$and$ultimately$will$improve$our$understanding$of$
the$pathophysiology$of$these$disorders.$For$example,$the$delineation$of$ANE$and$the$




pandemic$ infections$ has$ been$ limited$ to$ case$ reports$ and$ small$ series,$ from$ single$
centres.$ In$ addition,$ comparisons$ across$ these$ has$ been$ made$ more$ difficult$ as$





in$ adults$ and$ children$ across$ the$ UK$ applying$ standardised$ case$ definitions.$ $ This$








A$ national$ multicentre$ surveillance$ study$ of$ children$ and$ adults$ was$ performed$
through$ the$ British$ paediatric$ neurology$ surveillance$ unit$ [BPNSU<$
http://www.bpnsu.co.uk],$ and$ British$ neurological$ surveillance$ unit$ [BNSU<
http://www.theabn.org/what<we<do/bnsu.html],$ respectively,$ between$ February$
2011$to$February$2013;$the$surveillance$allowed$reporting$of$current$cases,$or$those$
in$the$preceding$6$months.$Cases$were$notified$by$doctors$ in$response$to$a$monthly$
email$ to$ all$ members$ of$ the$ British$ Paediatric$ Neurology$ Association$ and$ the$
Association$of$British$Neurologists$respectively.$In$addition$the$regional$microbiology$
laboratories$ for$ adults$ and$ paediatrics$ in$ the$ Northwest$ Neurological$ Infections$
Network$was$screened$for$patients$undergoing$investigation$for$influenza.$In$addition,$
colleagues$ at$ a$ large$ specialist$ children’s$ hospital$ in$ London$ and$ large$ regional$






throat$ or$ nasal$ swab,$ respiratory$ secretions,$ serum$or$ CSF.$ Clinical$ case$ definitions$
were$adapted$from$those$used$previously$for$CNS$infections$based$on$the$presenting$









Encephalopathy! only$ <$ alteration$ in$ consciousness$ including$ behavioural$ changes$
with$no$evidence$of$inflammation$in$the$CNS.$
Encephalitis$ –$ encephalopathy$ (as$ above)$with$ evidence$of$ CNS$ inflammation$ (CSF$
white$cell$count$>4/ml,$or$MRI$consistent$with$inflammation).!
Meningism! only! –$ Meningism$ (headache$ with$ neck$ stiffness$ and/or$ photophobia)$




Meningoencephalitis$ –$ Meningism$ and$ encephalopathy$ (as$ detailed$ above)$ with$
evidence$of$CNS$inflammation$(as$detailed$above)!





Following$ online$ notification$ of$ each$ case,$ a$ standardised$ data$ collection$ pro$ forma$
was$ sent$ to$ the$notifying$ clinician$ to$ request$ detailed$ clinical$ information$ including$
the$ presentation,$ investigations$ and$ the$ Glasgow$ outcome$ score$ (Jennett$ and$ Bond$


























and$ 1$ had$ meningoencephalitis.$ Two$ adults$ had$ encephalopathy$ with$ movement$
disorder,$1$had$encephalitis,$and$1$had$Guillain<Barre$syndrome$[GBS].$For$7$patients,$
6$ children$ and$ 1$ adult,$ the$ encephalopathy$ syndrome$ was$ documented;$ 4$ acute$
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necrotising$ encephalopathy$ [ANE],$ 1$ acute$ infantile$ encephalopathy$ predominantly$






San<Filippo$ syndrome,$ Trisomy$ 21,$ Wolf<Hirschhorn$ syndrome,$ and$ idiopathic$
generalised$ epilepsy,$ and$ 2$ with$ developmental$ delay$ and$ epilepsy$ of$ unknown$
aetiology.$ No$ cases$ were$ immunosuppressed.$ Because$ this$ was$ a$ surveillance$
programme,$ethnicity$and$travel$history,$which$might$be$unique$identifiers,$were$not$
















































































































































Influenza$A$was$detected$by$PCR$ in$ the$respiratory$secretions$of$21$ [84%]$cases,$of$
which$20$[95%]$were$the$H1N1$[2009]$subtype,$and$influenza$B$was$detected$in$the$
respiratory$ secretions$ of$ 4$ [16%]$ cases.$ Two$ cases$ had$ co<infection$ with$




tested$ for$ plasma$ ammonia,$ liver$ function,$ renal$ function,$ electrolytes$ and$ glucose$





Cerebrospinal$ fluid$ was$ examined$ for$ 18$ [72%]$ patients;$ 7$ had$ clinical$
contraindications$ to$ a$ LP.$ CSF$ was$ abnormal$ in$ 4$ [22%]$ cases:$ 3$ had$ pleocytosis$










6$ showed$ diffuse$ slowing$ of$ the$ background$ activity$ in$ keeping$ with$ an$
encephalopathy$[one$also$had$some$additional$focal$right$temporal$changes];$2$were$








Twenty$ [80%]$ required$ admission$ to$ an$ intensive$ care$ unit:$ $ the$ median$ [range]$
length$of$stay$was$3$ [1<67]$days.$Oseltamivir$was$commenced$ in$23$[92%]$patients.$
Presumptive$ antibiotic$ therapy$with$ a$third$ generation$ cephalosporin$ for$ suspected$
meningitis$was$started$for$18$[72%]$patients,$9$of$whom$also$received$clarithromycin.$









Case! 4! A! Acute! infantile! encephalopathy! predominantly! affecting! the! frontal!
lobes![AIEF]$
A$1$year$old$boy$presented$with$a$2<day$coryzal$illness.$On$examination$he$was$floppy,$
with$ respiratory$distress,$ circulatory$ shock$ and$decorticate$posturing.$A$plain$ chest$
radiograph$ demonstrated$ patchy$ changes$ bilaterally.$ CT$ brain$ scan$ was$ normal.$
Intensive$ care$ was$ required$ and$ antimicrobial$ treatment$ included$ cefotaxime,$
clarithromycin,$aciclovir$and$oseltamivir.$$
$$
Respiratory$ secretions$ were$ positive$ by$ PCR$ for$ influenza$ A:H1N1.$ Alanine$
transaminase$ [ALT]$ was$ raised$ [1319$ IU/L].$ The$ MRI$ brain$ scan$ [day$ 10]$
demonstrated$ cerebral$ atrophy$ and$ bilateral$ symmetrical$ restricted$ diffusion$
involving$in$the$frontal$cortex.$He$had$severe$sequelae:$tracheostomy$insertion,$and$at$
six$months$he$was$unable$to$sit$unaided$or$use$his$hands$for$purposeful$activities$and$






















treatment$ included$ ceftriaxone$ and$ aciclovir.$ During$ intubation$ she$ became$
bradycardic$and$required$cardiopulmonary$resuscitation.$
$
She$ developed$ acute$ renal$ and$ hepatic$ failure,$ coagulopathy,$ hypernatraemia$ and$
lactic$acidosis.$ALT$was$markedly$raised$[3192$IU/L].$A$CT$brain$scan$on$admission$
demonstrated$ diffuse$ cerebral$ oedema.$ She$ received$ a$ single$ dose$ of$mannitol$ and$
antimicrobial$ cover$ was$ broadened$ to$ include$ cefotaxime,$ clarithromycin,$








left<sided$ pleuritic$ chest$ pain,$ dyspnoea$ and$ pyrexia.$ A$ plain$ chest$ radiograph$
demonstrated$ left$ lower$ lobe$ consolidation.$ She$ was$ commenced$ on$ continuous$




Admission$ blood$ cultures$ grew$ S.# pneumoniae$ and$ urine$ PCR$ for$ pneumococcal$
antigen$was$positive.$Antibiotic$cover$was$narrowed$ to$ intravenous$benzylpenicillin$
according$ to$ sensitivities,$ and$ hydrocortisone$ was$ added.$ Her$ throat$ swab$ was$
positive$ for$ influenza$A:H1N1.$CT<brain$scan$on$admission$demonstrated$significant$
cerebral$ oedema,$ and$ EEG$ reflected$ severe$ encephalopathy.$ She$ was$ treated$ with$










2000).$ Since$ the$ emergence$of$ novel$ influenza$A:H1N1$ there$has$been$ considerable$




Prevention$ 2009).$ Subsequently,$ paediatric$ case$ series$ have$ described$ a$ variety$ of$
neurological$manifestations$ranging$in$severity$from$febrile$seizures$to$specific$acute$
encephalopathy$ syndromes$ associated$ with$ poor$ outcomes$ (Farooq$ et$ al$ 2012;$
Kawashima$ et$ al$ 2012;$ Khandaker$ et$ al$ 2012;$ Okumura$ et$ al$ 2013).$ The$
corresponding$adult$literature$is$predominantly$confined$to$single$case$reports$(Cisse$
et$al$2010).$There$is$limited$evidence$that$influenza$A:H1N1$is$associated$with$more$
severe$ forms$ of$ acute$ encephalopathy$ compared$with$ pre<2009$ influenza$ subtypes,$
although$ this$ may$ reflect$ reporter$ and$ publication$ bias$ (Ekstrand$ et$ al$ 2010).$ The$
estimated$ incidence$ of$ neurological$ manifestations$ has$ been$ estimated$ at$ 1.2$ per$
100,000$ symptomatic$ H1N1$ infections$ (Glaser$ et$ al$ 2012).$ However,$ good$
epidemiological$data$are$limited,$due$in$part$to$a$lack$of$standardised$case$definitions,$
such$ as$ the$ generic$ term$ ‘influenza<associated$ encephalopathy/encephalitis’$ or$
relying$ on$ clinical$ features$ alone$ (Ekstrand$ 2012;$ Glaser$ et$ al$ 2012).$ Moreover,$
studies$ have$ been$ limited$ small$ numbers$ reported$ from$ single$ centres,$ and$ no$
previous$systematic$surveillance$programme$has$been$reported.$$
$
As$previous$ case$ series$have$ typically$been$ retrospective$and$ restricted$ to$ children,$
we$applied$clinical$case$definitions$to$undertake$the$first$surveillance$study$through$
British$ adult$ and$paediatric$neurological$ surveillance$units.$Most$ cases$ in$our$ study$
presented$during$the$period$when$influenza$A:H1N1$was$the$predominant$subtype$in$
circulation,$ which$ thus$ accounts$ for$ the$ majority$ of$ isolates$ in$ our$ cohort$ (Health$
Protection$ Agency$ 2011).$ Neurological$ manifestations$ were$ commonly$ observed$ in$
children$with$pre<existing$neurological$diagnoses,$ an$unexplained$but$well<reported$
phenomenon$ (Yildizdas$ et$ al$ 2010;$ Kawashima$ et$ al$ 2012;$ Khandaker$ et$ al$ 2012;$




saw$ GBS$ in$ one$ adult,$ consistent$ with$ previous$ reports$ (Sivadon$ et$ al$ 2009).$ In$





clinical$ features.$ ANE,$ first$ described$ by$ Mizuguchi$ in$ 1995,$ is$ characterised$ by$
bilateral,$ symmetrical$necrotic$ lesions$affecting$ the$ thalami$ (Mizuguchi$ $ et$ al$1995).$
While$influenza$is$the$most$common$associated$pathogen,$human$herpes$virus$6$has$
also$been$frequently$described$(Mizuguchi$et$al$1995;$Hoshino$et$al$2012).$Supportive$
investigations$ for$ ANE$ include$ elevated$ serum$ aminotransferases,$ a$ raised$ CSF$
protein$without$a$pleocytosis$and$characteristic$neuroimaging.$The$child$with$atypical$
neuroimaging$[case$15]$had$more$prominent$brainstem$lesions.$However,$a$previous$
influenza<related$ encephalopathy$ prompted$ testing$ for$ the$ RANBP2$ mutation.$ She$
tested$positive$for$a$previously$described$RANBP2$mutation$[p.Ile656Val],$as$did$her$
mother$and$maternal$grandmother.$Mutations$of$RANBP2,$a$nuclear$pore$protein,$are$
associated$ with$ familial$ and$ recurrent$ ANE$ characterized$ by$ autosomal$ dominant$
inheritance$and$incomplete$penetrance$(Neilson$et$al$2009).$ $Particular$markers$of$a$




The$ other$ paediatric$ AES$ cases$ we$ identified$ [HSES$ and$ AIEF]$ had$ typical$




multi<system$ dysfunction$ and$ coagulopathy$ (Levin$ et$ al$ 1983).$ Neuroimaging$
typically$ demonstrates$ cerebral$ oedema$ (Mizuguchi$ et$ al$ 2007).$ Various$ pathogens$
have$ been$ linked$ to$ the$ condition$ including$ rotavirus$ and$ adenovirus$ (Rinka$ et$ al$









the$ brain$ and$ spinal$ cord,$with$ characteristic$ EEG$ and$MRI$ findings$ (Alemdar$ et$ al$
2006;$ Lann$ et$ al$ 2010).$ It$ has$ been$ associated$ with$ several$ infections,$ including$
Mycoplasma#pnuemoniae#and$Epstein<Barr$virus$(Catalan$et$al$2009;$Befort$et$al$2010).$




encephalopathy$with$ biphasic$ seizures$ and$ late$ reduced$ diffusion$ [AESD]$ and$mild$







reports$ in$ the$ published$ literature,$ we$ propose$ an$ expanded$ version$ of$ the$










identified$ in$ the$CSF$ (Fujimoto$ et$ al$ 1998;$ Ito$ et$ al$ 1999).$There$ is$unlikely$ to$be$ a$
single$ mechanism$ underlying$ the$ pathophysiology$ of$ the$ wide$ spectrum$ of$
neurological$ manifestations$ of$ influenza.$ Some$ have$ suggested$ that$ duration$ of$
influenza<like$ illness$ preceding$ neurological$ manifestations$ may$ afford$ distinction$
into$two$broad$categories:$a.$acute$–$in$association$with$an$innate$immune$response$





(Fujimoto$ et$ al$ 1998;$ Ichiyama$ et$ al$ 2004).$ Adaptive$ immune<mediated$
pathophysiology$ is$ associated$ with$ several$ sub<acute$ neurological$ syndromes,$
including$ GBS$ (Costiniuk$ et$ al$ 2011).$ Although$ none$ of$ those$ in$ our$ cohort$ had$




Co<infection$with$S.#pneumoniae#was$observed$ in$ two$patients$ [cases$18$&$23];$both$
developed$malignant$cerebral$oedema$and$died.$Pneumococcal/influenza$respiratory$
co<infection$ is$ a$ recognised$ distinct$ clinical$ entity$ associated$ with$ poor$ outcome$
(Palacios$ et$ al$ 2009;$ Launes$ et$ al$ 2012).$While$ the$ pathophysiology$ underlying$ the$
synergy$between$ the$ two$organisms$ is$poorly$understood,$proposed$ factors$ include$
the$role$of$influenza$virulence$factors$in$epithelial$damage$and$subsequent$facilitated$
entry$ of$ pneumococcus,$ as$ well$ as$ up<regulation$ of$ the$ inflammatory$ response$
(McCullers$et$al$2006).$
$
There$ are$ no$ randomised$ trials$ informing$ the$ management$ of$ AES.$ Early$ steroid$





Influenza$ vaccine$ is$ efficacious$ in$ preventing$ influenza$ infection$ in$ children$ over$ 2<
 
93 
years$ of$ age,$ and$ also$ in$ reducing$ hospitalisation$ (Jefferson$ et$ al$ 2008;$ Gilca$ et$ al$
2011).$None$of$our$cohort$were$vaccinated$against$influenza$A:H1N1.$However,$8$had$
clinical$ indications$ for$ vaccination,$ including$ the$ 6$ with$ pre<existing$ neurological$
diagnoses$and$2$with$asthma$[cases$13$and$23];$3$of$these$died,$and$the$remaining$5$
all$had$poor$outcomes$(Sammon$et$al$2012).$$Currently$there$is$no$real<time$platform$
to$ assess$where$ patients$ are$ and$ are$ not$ receiving$ vaccinations.$ $Nevertheless,$ it$ is$
pivotal$ in$ the$ monitoring$ the$ effectiveness$ of$ national$ vaccination$ programmes$ to$
have$these$data.$
$







the$ reporting$ was$ via$ neurologists$ rather$ than$ general$ clinicians,$ and$ the$ majority$
required$ITU$support$and/or$died.$$
$
Public$ Health$ England$ collects$ data$ on$ a$ 4$monthly$ basis$ from$ general$ practitioner$
[GP]$practices$(and/or$Primary$Care$Trust$Flu$co<ordinators)$in$England$through$the$
ImmForm$website$ (Begum$et$ al$ 2013).$Although$84%$of$GP$practices$ responded$ to$
the$most$recent$annual$survey$(2012/2013),$weekly$collections$are$only$available$in$a$





record$ all$ vaccinations$ performed$ by$ other$ healthcare$ providers$ (e.g.$ pharmacies,$
antenatal$ and$ other$ specialist$ clinics$ etc),$ data$ are$ not$ available$ for$ those$ not$
registered$with$a$GP$practice,$or$for$those$who$refuse$the$vaccine,$also$data$are$only$
collected$ for$ specific$ groups$ relating$ to$ pre<determined$ ‘at<risk’$ groups$ at$ need$ of$
vaccination$and$are$not$able$to$provide$wider$data$of$relevance$to$the$establishment$
of$ herd$ immunity.$ In$ addition,$ such$ approaches$ require$ review$ with$ structural$
changes$ within$ the$ NHS,$ such$ as$ the$ abolition$ of$ Strategic$ Health$ Authorities,$ and$
Primary$Care$Trusts,$the$development$of$Clinical$Commissioning$Groups$and$changes$
in$ software$used$by$ individual$GP$practices$ to$ store$data.$Although$ there$ is$ a$move$
towards$ automation$ of$ these$ processes,$ these$ have$ been$ instituted$ to$ answer$ one$
specific$ question,$ i.e.$ has$ the$ WHO$ target$ of$ $ $ >75%$ of$ at<risk$ individuals$ been$
vaccinated$ for$ influenza$ has$ been$met$ in$ this$ timeframe?$Therefore,$ the$mandatory$
need$for$GP$practices$to$have$methods$to$submit$this$data$led$to$the$development$of$






using$ new$ technological$ approaches,$ such$ as$ ‘crowd<sourcing’$ using$ Google$ ©$ ‘Flu$
Trends$ data$ (Ginsberg$ et$ al$ 2009;$ Arnold$ 2013).$ $ The$ success$ of$ future$





In$conclusion,$ in$ this$paediatric$and$adult$UK$study$ that$ I$helped$ to$co<ordinate,$we$
attempted$ to$use$predetermined$diagnostic$criteria$applied$ to$clinical$data$collected$




spectrum$ of$ neurological$ manifestations$ of$ influenza.! Specific$ AES$ had$ a$ worse$
outcome$ and$ were$ reported$ more$ frequently$ in$ children.$ These$ data$ are$ used$ to$




following$ the$acute$event$and$no$real<time$reporting$systems$ for$encephalitis$are$ in$
use$in$the$UK.$Therefore,$I$took$this$experience$forward$to$explore$in$more$detail$the$
current$disease$reporting$systems$pertinent$ to$acute$viral$encephalitis$ to$determine$















































































































































































































































































































































































































































































































































































(3 month Period: CSF sample  and/or Intravenous Aciclovir and/or Intravenous Meningitis Protocol Antibiotic)
(n=385)
Excluded















(Cases not meeting Clinical Case Definitions)
(n=173)
Clinical Diagnosis of CNS infection























































































































































































































Diagnosis! Sensitivity! Specificity! PPV! NPV! OR!! p"value!




(%)! !! !! !! !! (95%!CI)! !!
!
History! ! ! ! ! ! ! ! ! ! ! !
Fever! 10! 8! 3! 21!(48)! 42!(24)! 44! 75! 32! 83! 2.85!(1.3685.98)! 0.002!
Febrile!Prodrome! 8! 7! 4! 19!(43)! 63!(36)! 43! 64! 23! 81! 1.33!(0.6482.74)! 0.409!
Headache! 17! 11! 5! 33!(75)! 118!(68)! 75! 32! 22! 83! 1.40!!(0.6283.19)! 0.382!
Nausea! 10! 8! 4! 22!(50)! 84!(49)! 50! 51! 21! 80! 1.06!!(0.5282.16! 0.864!
Vomiting! 10! 5! 4! 19!(43)! 63!(36)! 42! 59! 21! 79! 1.33!!(0.6482.74)! 0.409!
Photophobia! 12! 6! 0! 18!(41)! 55!(32)! 46! 67! 27! 83! 1.49!!(0.7183.09)! 0.253!
Immunocompromised! 1! 0! 1! 2!(5)! 8!(5)! 5! 95! 20! 80! 1.88!!(0.26810.54)! 0.350!
Travel! 3! 3! 0! 6!(14)! 7!(4)! 14! 96! 46! 81! 3.74!!(1.04813.35)! 0.028!
Seizures! 2! 1! 5! 8!(18)! 12!(7)! 10! 93! 27! 79! 2.98!!(1.0288.58)! 0.021!
Speech!Disturbance! 1! 1! 2! 4!(9)! 15!(9)! 9! 91! 21! 80! 1.05!!(0.2883.65)! 0.564!
Neck!Stiffness! 8! 7! 1! 16!(36)! 59!(34)! 42! 67! 25! 81! 1.10!!(0.5282.32)! 0.778!
!
Examination! ! ! ! ! ! ! ! ! ! ! !
Drowsiness! 3! 2! 6! 11!(25)! 25!(14)! 25! 86! 31! 82! 1.97!!(0.8284.71)! 0.093!
Confusion/Behaviour!change! 0! 4! 12! 16!(36)! 33!(19)! 36! 81! 33! 83! 2.42!!(1.1185.29)! 0.014!
GCS<15! 0! 5! 5! 10!(23)! 30!(17)! 23! 83! 25! 81! 1.40!!(0.5883.35)! 0.411!
Pyrexia! 9! 10! 3! 22!(50)! 43!(25)! 50! 75! 34! 86! 3.02!!(1.4586.34)! 0.001!
Rash! 4! 1! 1! 6!(14)! 15!(9)! 14! 91! 29! 81! 1.66!(0.5384.98)! 0.320!



































































































































! (n=48)% (n=88)% %
All%patients% 7!(0.5Q312)! 3!(0.3Q312)! 0.002!
Imaging%then%LP%% 7.5!(0.5Q312)! 3!(0.5Q312)! 0.004!




























































































































































The!most! common! cause! of! sporadic! viral! encephalitis! is! infection!with! the! herpes!
viruses! HSV! and! VZV,! with! the! latter! being! one! of! the! most! common! viral! CNS!





viral! encephalitis,! as! viral! culture! of! CSF! is! typically! negative! despite! active! CNS!
infection! (Wildemann! 1997;! Domingues! et! al! 1998).! Subsequently,! realQtime!
quantitative! PCR! [qPCR]! has! been! used,! both! in! research! and! clinical! settings,! to!
quantify!the!viral!load!in!the!CSF!(MunozQAlmagro!et!al!2008).!Previous!studies!have!
identified!that,!generally!across!the!range!of!suspected!CNS!infections,!the!CSF!is!most!
likely! to! be! positive! by! PCR! in! those! who! have! the! LP! between! 3Q14! days! after!
symptomQonset! and! that! there! is! a! progressive! decline! in! the! proportion! of! CSF!
samples!positive!from!day!5!after!symptom!onset!(Davies!et!al!2005).!However,! it! is!
unclear! if! the! declining! rates! of! pathogen!detection! reflect! declining! viral! load!with!
time,!or!whether!this!is!simply!that!those!patients!with!a!nonQviral!cause!tend!to!have!
the! LP! later.! This! is! of! importance! as! several! studies! have! identified! delays! in!




































I! conducted! qPCR! using! a! validated! commercial! assay! [Artus! VZV! LCQPCR,! Qiagen!
Group],!with!a!uniform!volume!of!CSF!and!processed!this!using!a!LightQCycler!analyser!
[Roche!Diagnostics!TM! 2007].! ! Patients!were! dichotomised! into! those!with! high! and!
low! viral! loads! as! described! previously,! with! a! high! viral! load! defined! as! >5.0x104!
copies/μL!(Domingues!et!al!1998).!All!CSF!samples!also!underwent!PCR!for!HSV1!and!




with! national! guidelines! (Government,! UK! 1998).! Outcome! was! assessed!
retrospectively!from!the!notes!using!the!GOS!score,!as!described!previously!(Mailles!et!
al! 2012;! Poissy! et! al! 2012).! A! good! outcome!was! defined! as! those!with! a! GOS! of! 5!
[good!recovery]!and!a!poor!outcome!as!a!GOS!of!<5![moderate!disabilityQdeath].!The!









Analysis! was! performed! using! SPSS! [2009];! the! MannQWhitney! U! test! and! linear!
regression!performed!for!continuous!nonparametric!data;!chiQsquared!test!performed!
for!categorical!data;!and!Kendall's! tau! test!performed! for!nonparametric!correlation!
analysis.! A! p$ value$<0.05!was! defined! as! statistically! significant.! The! incidence!was!
























VZV: Varicella Zoster Virus
PCR: Polymerase Chain Reaction
All screened
(All CSF samples received by the regional virology laboratory over 5 year period)
(n= 608)
Excluded by screening
(PCR for VZV not performed)
(n= 572)
Identified by  screening




















































Score                            
(at discharge) 
1 M 74 N 15 1720 42 0.70 192 168 3 
2 M 64 Cyclophosphamide 14 28.73 9 0.35 106 N   3 * 
3 M 76 N 14 56,000 66 0.77 48 N 3 
4 M 20 N 15 1840 224 1.82 96 N 5 
5 F 29 HIV 14 160,000 48 1.44 8 N 4 
6 F 27 N NA 9860 200 NA 72 NA 5 
7 M 27 N 15 1510 158 1.12 120 24 5 
8 F 21 N 15 4.57 14 0.81 156 N 5 




NA 7,000,000 6 NA 96 NA 1 
10 M 73 NA NA 1.59 39 0.54 NA NA NA 
11 M 79 N 15 NA NA 0.66 189 N 4 
12 M 34 N 15 NA 78 1.58 96 N 5 
Glasgow outcome score: 5 little-minor disability; 4 moderate disability; 3 severe disability; 2 persistent vegetative state; 1 death 
* Glasgow Outcome Score 3 on admission and discharge 




















































































































































































































Viral! encephalitis! is! a! severe! life0threatening! infection! of! the! CNS! with! an! annual!
incidence! of! 2.9010/100,000! (Granerod! et! al! 2010).! VZV! accounts! for! up! to! 29%!of!
cases!of!viral!CNS!infection,!with!encephalitis!being!the!most!common!manifestation!
(Persson!et!al!2009).!Despite!advances!in!PCR!the!aetiology!remains!unknown!in!300
40%! of! patients! with! suspected! viral! encephalitis! (Granerod! et! al! 2010).! Previous!
studies!have! identified!delays! in!performing! the!LP! in!patients!with! suspected!viral!
encephalitis! (Bell! et! al!2009;!Michael! et! al!2010).!Delays! in!performing! the!LP!have!
been! shown! to! be! associated! with! a! lower! proportion! of! cases! in! which! a! virus! is!
identified!(Davies!et!al!2005).!However,!it!is!unclear!if!this!reflects!a!reduction!in!viral!
load!over!time!or!whether!patients!with!non0viral!causes!of!encephalitis!undergo!the!
LP! later.! In! those!patients! in!whom!a!virus! is! identified,! there! is! a! varied!prognosis!
ranging! from! complete! recovery! to! severe! cognitive! impairment! and! epilepsy,! or!







example! it! can! distinguish! between! a! low! viral! load,! which! might! represent! latent!
































Previous! studies! of! VZV! infection! have! found! that! patients! with! encephalitis! had!
higher! CSF! viral! loads! than! those! with! meningitis! and! that! those! who! required!
intensive!care!also!had!higher!loads!(Aberle!et!al!2005;!Persson!et!al!2009).!However,!
neither!assessed!the!viral! load! in!relation!to!outcome!and!neither!assessed!the!viral!
load! in! VZV! encephalitis! in! relation! to! the! time! from! symptom! onset! to! LP.! In!HSV!
encephalitis,! six! previous! studies! found!no! clear! correlation!between! viral! load! and!
outcome! overall,! (Wildemann! et! al! 1997;! Domingues! et! al! 1998;! Kamei! et! al! 2004;!
Ruzek!et!al!2007;!Munoz0Almagro!et!al!2008;!Poissy!et!al!2012)!though!two!did!find!
that! those! with! either! very! high! viral! loads! or! an! initial! rise! in! viral! load! after!
treatment!had!a!worse!outcome!(Kamei!et!al!2004;!Ruzek!et!al!2007).!One!additional!
study!in!adults!found!a!higher!viral!load!in!patients!with!poor!outcome!(Domingues!et!



















delay! in! the!LP!was!associated!with!a! significant!decline! in!viral! load.!Although! this!
may! in! part! reflect! those! with! less! severe! clinical! presentations! having! the! LP!
performed! later,! a! potential! implication! is! that! for! patients! with! suspected! viral!
encephalitis,!the!greatest!likelihood!of!identifying!a!pathogen!is!if!the!LP!is!performed!







the! majority,! I! wanted! to! determine! whether! the! introduction! of! a! simple! clinical!








































































































































'' '' PreCLP'Pack'' PostCLP'Pack' P'value'
'
Number'of'Patients' ' 52! 41! '
Age'[Median'(range)]' ' 39!(18M78)! 37!(17M82)! 0.19!
Male'(%)' ' 30!(58)! 29!(71)! 0.5!




Any'major'error' 44!(85)! 20!(49)! 0.0003!
No'CSF!Glucose' 9!(17)! 0! 0.005!
No'Plasma'Glucose' 28!(54)! 0! 0.0001!









No'CSF'Virology' 44!(85)! 20!(49)! 0.0003!
Positive'Investigations'
(%)'
CSF'Bacterial'culture' 2!(4)! 2!(5)! 1!
'CSF'Bacterial'PCR!' 1!(2)! 2!(5)! 0.49!
CSF'Viral'PCR' 2!(4)! 5!(12)! 0.16!
All'CSF'PCR' 3!(6)! 7!(17)! 0.09!
All'CSF'PCR'for'patients'with'a'
CSF'pleocytosis' 3!(17)! 7!(50)! 0.059!
Time'to'LP'(hours)''''''













































































































































































































































































































































































































































Univariate( analysis( of( mediators( in( CSF( and( serum( identified( differences( in(
concentrations(for(several(mediators(between(the(aetiological(groups([Figure(13(
and( 14].( In( both( serum( and( CSF(MPO(was( present( at( lower( concentrations( in(
samples(of( immuneAmediated(aetiology.( In(serum(ICAM(was(highest( in(patients(
with(an(infective(aetiology(and(TNFα(in(those(with(immuneAmediated(aetiology.(
In(CSF(concentrations(of( IL1β( and( IL10(were(higher( in( immuneAmediated( than(



























Hierarchical( cluster(analysis( identified( two(broad(clusters(of(mediators( in(both(
serum(and(CSF.(The(group(A(cluster(contained(IL1α,(IL1β(and(IL10,(in(addition(to(
other(mediators;( in(CSF( these( same(mediators(were( identified( in(group(A(with(
the(addition(of(IL1RA.(The(group(B(cluster(contained(IFNα,(IFNβ,(IFNγ(and(IFNο,(






































































































































Number*(percentage)*of*samples*in*which*identified* (n=7)* (n=6)* (n=5)*
Psittacid*herpesvirus*1*** 2*(29)* 1*(17)* 0*
Varicella:zoster*virus*(DNA*polymerase*catalytic*subunit)*** 1*(14)* 0* 0*
Human*immunodeficiency*virus*type*2*subtype*A*(Gag:Pol)*** 1*(14)* 1*(17)* 0*
Human*papillomavirus*type*22*(Regulatory*protein*E2)** 5*(71)* 3*(50)* 0*
Coronavirus*(Replicase*polyprotein*1ab)*** 1*(14)* 1*(17)* 0*
Feline*sarcoma*virus*(Tyrosine:protein*kinase)* 6*(86)* 4*(67)* 0*
Aquareovirus*C*(RNA:directed*RNA*polymerase)* 1*(14)* 6*(100)* 0*
Enterobacteria*phage*T7*(Gene*4.3)* 1*(14)* 0* 0*
Invertebrate*iridescent*virus*6*(Putative*helicase)* 1*(14)* 0* 0*
Apple*stem*grooving*virus*(Genome*polyprotein)* 1*(14)* 0* 0*














































































































been* increasing* interest* as* to* whether* differences* in* these* profiles* might* predict*
disease* severity* and* outcome* in*within* a* given* aetiology* of* encephalitis.* In* the*most*
common*form*of*encephalitis,*that*due*to*viral*infection,*a*pro:inflammatory*profile*of*
these* mediators* has* been* identified* to* correlate* with* disease* severity* and* poor*
outcome* in* those*with* sporadic* viral* encephalitides* due* to* Enterovirus* and* Japanese*
encephalitis* virus* (Winter* et* al* 2004;* Griffiths* et* al* 2012)* However,* although* some*
work*has*been*conducted*in*cellular*and*animal*models,*I*sought*to*determine*whether*
the*profiles* of* these*mediators*may* correlate*with* clinical* severity* and*outcome,* and*




































































































































































































** Serum' CSF' p'value'
*
CCL2* 0.15*[:0.65:0.41]* 0.62*[:0.24:1.93]* 0.005*
CCL5* 1.39*[:0.85:2.79]* :0.37*[:1.04:1.02]* 0.058*
CXCL10* 0.58*[:0.04:1.72]* 1.35*[0.37:2.21]* 0.04*
Granzyme*B* :0.25*[:1.15:*0.86]* 0.05*[:0.39:0.86]* 0.04*
ICAM* 2.05*[0.40:2.80]* 1.46*[1.21:2.43]* 0.19*
IFNg* :0.77*[:1.56:*:0.59]* :0.47*[:0.99:0.37]* 0.003*
IL10* :0.73*[:2.10:*0.01]* :0.43*[:0.63:0.71]* 0.007*
IL1a* :0.42*[:0.61:*:0.04]* :0.20*[:1.60:*0.10]** 0.05*
IL1RA* 0.16*[:0.11:1.61]* 1.23*[0.24:2.06]* 0.003*
IL6* :0.10*[:0.34:0.25]* 0.62*[:0.54:1.17]** 0.015*
IL8* :0.03*[:2.12:1.19]* 0.58*[:0.03:2.27]* 0.0004*
MMP2* 1.31*[:1.77:2.03]** :0.09*[:2.15:0.42]** 0.005*
MMP3* 0.76*[:2.25:1.77]** :1.42*[:2.15:0.38]* 0.002*
MMP7* 0.68*[:1.44:1.77]** :1.01*[:1.87:*:0.29]* 0.02*
MMP13* :1.31*[:2.11:*:0.20]** :3.24*[:3.33:*:2.45]* 0.004*










For*all*patients,* the*concentration*of* IL10* in* the*CSF*was*significantly*higher* in* those*














































































CSF& IFNο$ %0.39$[%0.94$to$0.41]$ %0.34$[%0.76$to$0.39]$ 0.20$ %0.33$[%0.52$to$0.41]$ %0.46$[%0.56$to$0.08]$ 0.25$
&
IFNγ$ %0.47$[%0.88$to$0]$ %0.47$[%0.99$to$0.61]$ 0.86$ %0.53$[%0.88$to$%0.11]$ %0.02$[%0.99$to$0.13]$ 0.13$
&
CCL5$ %0.40$[%1.17$to$0.71]$ %0.57$[%1.04$to$1.02]$ 0.20$ %0.44$[%0.71$to$0.48]$ %0.22$[%1.04$to$1.02]$ 0.79$
&
ICAM$ 1.48$[1.05$to$2.64]$ 1.49$[0.79$to$2.69]$ 0.97$ 1.46$[1.05$to$2.07]$ 1.44$[1.21$to$2.43]$ 0.93$
&
IL1α$ %0.16$[%0.88$to$0.12]$ %0.16$[%0.50$to$0.06]$ 0.96$ %0.04$[%0.43$to$0.04]$ %0.25$[%0.50$to$0]$ 0.33$
&
IL1β$ %0.41$[%1.10$to$%0.16]$ %0.51$[%0.95$to$%0.11]$ 0.56$ %0.43$[%1.06$to$%0.24]$ %0.65$[%0.92$to$%0.28]$ 0.54$
&
MPO$ 1.01$[0$to$1.49]$ 1.02$[%0.87$to$2.00]$ 0.99$ 1.03$[0.49$to$1.42]$ 1.08$[%0.87$to$1.62]$ 0.93$
&
CXCL10$ 1.35$[0$to$2.28]$ 1.56$[%0.07$to$2.35]$ 0.33$ 1.37$[0.37$to$1.92]$ 1.18$[0.41%1.96]$ 0.93$
&
CCL2& 0.36&[0.01&to&0.88]& 0.7&[=0.24&to&1.93]& 0.02& 0.49$[0.09$to$0.72]$ 0.78$[%0.24$to$1.93]$ 0.33$
&
CCL3$ %0.15$[%0.88$to$%0.01]$ %0.19$[%1.67$to$0.16]$ 0.8$ %0.27$[%0.45$to$%0.11]$ %0.13$[%1.67$to$%0.08]$ 0.43$
&
IL10$ %0.48$[%1.70$to$0.10]$ %0.53$[%0.75$to$0.01]$ 0.31$ %0.44$[%0.66$to$0.36]$ %0.31$[%0.63$to$0]$ 0.69$
&
IL1RA$ 0.54$[0.13$to$1.83]$$ 0.63$[%0.01$to$1.67]$ 0.73$ 0.54$[0.24$to$1.84]$ 1.43$[0.73$to$1.67]$ 0.13$
&
IL8$ 0.58$[%0.03$to$1.47]$$ 0.55$[%0.42$to$2.03]$ 0.8$ 0.58$[%0.03$to$1.47]$ 0.73$[0.17$to$2.03]$ 0.93$
&
VCAM$ 1.2$[%0.37$to$2.19]$$ 1.44$[%0.29$to$2.03]$ 0.44$ 1.43$[0.98$to$2.19]$ 1.31$[0.88$to$2.03]$ 0.79$
&
TNFα$ %0.58$[%1.52$to$%0.37]$ %0.68$[%1.26$to$%0.09]$ 0.75$ %0.55$[%1.11$to$%0.37]$ %0.81$[%1.00$to$%0.38]$ 0.33$
&
IL4$ %0.16$[%1.73$to$0.13]$ %0.22$[%1.66$to$0.18]$ 0.9$ %0.2$[%0.80$to$%0.01]$ %0.27$[%0.57$to$0]$ 1$
&
TRAIL$ 0.14$[%0.17$to$0.27]$ 0.24$[%0.04$to$0.69]$ 0.07$ 0.17$[0.09$to$0.24]$ 0.3$[%0.04$to$0.78]$ 0.33$
&
IL1α/IL1RA$ %0.3$[%1.18$to$0.25]$ %0.19$[%29.57$to$14.83]$ 0.58$ %0.07$[%0.68$to$0.17]$ %0.24$[%0.31$to$%0.10]$ 0.31$
&
IL1β/IL1RA& %0.74$[%1.59$to$%0.43]$ %0.6$[%107.06$to$25.02]$ 0.45$ =0.82&[=1.59&to&=0.57]& =0.46&[=0.61&to&=0.37]& 0.009*&
&
IL1α/IL10$ 0.07$[%19.03$to$1.45]$ 0.27$[%17.42$to$2.05]$ 0.27$ 0.05$[%19.03$to$0.46]$ 0.8$[%17.42$to$2.05]$ 0.15$
&
IL1β/IL10& 0.52&[=57.23&to&1.45]& 0.91&[=43.88&to&3.65]& 0.039& 0.66$[%57.23$to$1.39]$ 1.42$[%43.88$to$3.65]$ 0.31$
 202 
Serum& G%CSF$ %0.36$[%1.11$to$0.05]$ %0.49$[%1.29$to$0.77]$ 0.75$ %0.15$[%0.45$to$%0.06]$ %0.42$[1.2$to$0.45]$ 0.95$
&
GM%CSF$ %0.07$[%1.26$to$0.40]$ %0.37$[%1.39$to$0.54]$ 0.36$ 0.03$[%0.70$to$0.33]$ %0.06$[1.36$to$0.54]$ 0.39$
&
Granzyme$B$ %0.33$[%1.30$to$0.86]$ %0.37$[%1.182$to$0.32]$ 0.86$ %0.24$[%0.34$to$0.86]$ %0.81$[%1.15$to$0.32]$ 0.28$
&
IFNβ$ %0.38$[%2.43$to$0.28]$ %1.3$[%2.55$to$0.09]$ 0.22$ %0.21$[%0.91$to$0]$ %0.18$[%1.89$to$%0.09]$ 1$
&
IFNο$ %0.28$[%0.77$to$0.88]$ %0.19$[%0.71$to$0.60]$ 0.61$ 0.17$[%0.56$to$0.41]$ %0.31$[%0.70$to$0.26]$ 0.059$
&
IFNγ$ %0.78$[%1.16$to$%0.43]$ %0.82$[%1.66$to$0.18]$ 0.46$ %0.70$[%1.00$to$%0.59]$ %0.83$[%1.56$to$%0.29]$ 0.33$
&
ICAM$ 2.06$[0.78$to$2.85]$ 2.03$[%0.30$to$4.40]$ 0.90$ 2.06$[0.78$to$2.39]$ 1.90$[0.40$to$2.80]$ 0.85$
&
IL1α & %0.86$[%1.69$to$0.11]$ %0.86$[%1.93$to$0.06]$ 0.86$ =0.14&[=0.95&to&0.10]& =0.55&[=1.60&to&=0.08]& 0.04&
&
IL1β$ %0.95$[%1.85$to$%0.36]$ %1.22$[2.34$to$%0.07]$ 0.63$ %0.61$[%1.37$to$%0.36]$ %0.73$[%2.14$to$%0.07]$ 0.96$
&
MPO& 1.33&[=0.04&to&2.28]& 1.01&[=0.43&to&2.89]& 0.02& 1.54$[0.30$to$1.82]$ 0.92$[0.57$to$2.22]$ 0.49$
&
CXCL10$ 0.48$[%0.32$to$1.72]$ 0.56$[%0.17$to$1.87]$ 0.89$ 1.37$[0.13$to$1.72]$ 0.58$[%0.04$to$1.30]$ 0.14$
&
CCL2$ 0.08[%0.45$to$0.56]$ 0.10[%0.79$to$1.04]$ 0.85$ 0.21$[%0.28$to$0.41]$ 0.14$[%0.04$to$1.30]$ 0.33$
&
CCL3$ %0.33$[%1.49$to$%0.01]$ %0.48$[%1.34$to$%0.05]$ 0.1$ %0.35$[%0.53$to$%0.23]$ %0.27$[%0.91$to$%0.05]$ 0.87$
&
IL10$ %0.89$[%1.62$to$0.16]$ %0.88$[%2.45$to$0.05]$ 0.52$ %0.52$[%1.26$to$0.01]$ %0.91$[%2.10$to$%0.33]$ 0.18$
&
IL1RA& 0.62&[=0.15&to&1.61]& 0.23&[=0.26&to&1.04]& 0.004*& 0.48$[%0.01$to$1.61]$ 0.04$[%0.11$to$1.02]$ 0.37$
&
IL8& =0.13&[=1.51&to&2.21]& =0.59&[=2.47&to&1.19]& 0.02& %0.07$[%0.83$to$0.67]$ %0.04$[%2.12$to$1.19]$ 0.96$
&
VCAM$ 1.75$[0.68$to$2.30]$ 1.77$[%0.48$to$2.55]$$ 0.76$ 1.9$[1.03$to$2.30]$ 1.31$[%0.43$to$1.99]$ 0.12$
&
TNFα$ %0.8$[%0.91$to$%0.37]$ %0.89$[%1.67$to$%0.10]$ 0.76$ %0.61$[%0.91$to$%0.26]$ %1.02$[%1.67$to$%0.10]$ 0.07$
&
IL4$ %0.46$[%1.27$to$%0.03]$$ %0.56$[%1.39$to$0.19]$ 0.94$ %0.34$[%0.67$to$%0.10]$ %0.25$[%1.11$to$0.19]$ 0.79$
&
TRAIL$ 0.27$[%0.06$to$1.13]$ 0.21$[%0.11$to$1.30]$ 0.53$ 0.4$[0.16$to$0.49]$ 0.28$[0.02$to$0.73]$ 0.57$
&
IL1α/IL1RA$ %0.95$[%5.06$to$10.75]$ %1.22$[%243.56$to$34.72]$ 0.41$ %0.47$[%2.18$to$1.97]$ %0.62$[%56.12$to$24.51]$ 0.56$
&
IL1β/IL1RA$ %1.39$[%9.66$to$59.58]$ %2.02$[%239.23$to$59.24]$ 0.23$ %0.99$[%6.99$to$59.58]$ %0.79$[%84.69$to$32.78]$ 0.79$
&
IL1α/IL10& 0.78$[%37.20$to$8.61]$ 0.72$[%13.43$to$8.25]$ 0.82$ 0.03&[=37.20&to&0.76]& 0.55&[0.24&to&1.34]& 0.03&

















CSF! samples! to! determine! the! albumin! concentration! were! available! for! 22!
patients! (10! infective,! 6! immune*mediated,! and! 6! unknown! aetiology),! and!
paired! CSF! and! serum! samples! were! available! for! 20! (8! infective,! 6! immune*
mediated,! and! 6! unknown! aetiology).! Overall! there! was! a! positive! correlation!
between!the!CSF!albumin!and!the!CSF:serum!albumin!ratio!!(tau!b![95%CI]!0.55!
[0.26*0.83],!p=0.002).!Overall! there!was!a!higher!CSF!albumin!concentration! in!
those!with! infective! than! immune*mediate! aetiology! (364.5! [67.5*905]! vs! 67.5!



















and! GOS! score! (tau! b! *0.16! [*0.50*0.19],! p=0.4).! Nevertheless,! those! with! an!
elevated!CSF!WCC!had!a!higher!albumin! concentration! (250! [67.5*905]!vs!149!
[50.65*348.5],! p=0.049)! [Figure! 22b];! although! there! was! no! significant!
association!with!the!CSF:serum!albumin!ratio.!For!all!patients!the!only!mediator!
in! the! CSF! with! a! positive! correlation! with! the! CSF:serum! albumin! ratio! was!
VCAM!(0.50![0.20*0.81],!p=0.004)![Figure!22c],!and!the!concentration!of!CCL2!in!
the! CSF! approached! significance! (0.33! [*0.04*0.71],! p=0.057).! The!mediator! in!













the!diagnosis!was!made!by!HSV! antibody,! and!1! further! case!had!been!border!
line! low*positive! by! PCR! at! recruitment.! The! difference! between! the! median!
[range]! time! from!admission! to!CSF! sample!was!not! statistically! significant! for!
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those!for!whom!there!was!a!detectable!versus!undetectable!viral!load!(2![1*3]!vs!
11! [1*22]!days,!p=0.5).!The!cases!with!a!detectable!HSV!viral! load!had!a! lower!
median![range]!GOS!than!those!in!whom!HSV!DNA!was!not!detected!(2![1*3]!vs!5!






In! the! HSV! infected! BBB! model! there! was! a! progressive! decline! in! the! TEER!
greater!than!that!seen!in!the!control!sham*infected!model,!reflecting!increasing!

















levels! at! the! lowest! limit! end! of! detection! and! therefore! were! excluded! from!
further! analysis! as! the! could! not! be! accurately! quantified:! G*CSF,! IFNβ,! IFNγ,!
IFNο,! IL1α,! IL1β,! IL1RA,! IL4,! IL10,! CCL3,! CXCL9,! TNFα,!MPO,! eSelectin,!MMP8,!
MMP9,!and!IL17a.!
!
In! the!HSV! infected!BBB!model!higher! concentrations!of! ICAM! (496.81! [277.6*
1310.3]!vs!185.62![14.0*369.6],!p=0.007)!and!VCAM!(76.21![51.1*136.9]!vs!32.15!
























abluminal! samples! [Figure! 24].! The! median! concentrations! of! the! other!
mediators! did! not! differ! significantly! between! luminal! and! abluminal! samples.!
Discriminant! function! analysis! identified! three! mediators! (VCAM! [Wilks’!
lambda]! [0.448],! p=0.035;! ICAM! [0.089],! p=0.002;! MMP7! [0.018],! p=0.001)! as!
identifying! all! 8! samples! as! having! been! taken! from! the! luminal! or! abluminal!
sides.! In!addition,! the!rate!of!change!was!greater! in!samples!obtained! from!the!



























p&value&median!(range)! median!(range)! median!(range)! median!(range)!
[pg/μL]! [pg/μL]! [pg/μL]! [pg/μL]!
MMP7& 51.2!(40.0862.7)! 67.6!(59.0877.4)! 0.0003! 56.5!(39.0854.0)! 84.8!(64.9887.4)! 0.03!
CCL2& 2970.5'(1604.5,3324.4)' 3252'(2436.8,9180.0)' N/S'
' '
N/S!
CCL5& 136.0!(21.18451.7)! 695.6!(331.781116.9)! 0.003!
! !
N/S!
CXCL&10& 9.5!(5.0837.0)! 80.3!(18.68125.3)! 0.005!
! !
N/S!
ICAM& 196.5!(14.08364.5)! 499.4!(254.581310.3)! 0.02!
! !
N/S!
IL6&& 355.0!(11.981317.9)! 1280.1!(837.181512.6)! 0.005!
! !
N/S!
IL8& 697.6!(262.08808.8)! 1317.7!(856.281484.5)! 0.0006!
! !
N/S!
TRAIL& 60.6!(31.7887.0)! 85.5!(64.58104.1)! 0.002!
! !
N/S!
VCAM& 38.2'(12.2,64.7)' 67.7'(39.1,136.9)' N/S'
' '
N/S!











































































































































































































































































deleterious.! Particularly,! the! balance! between! the! IL1! family! and! antagonists,!
IL1RA! and! IL10,! was! associated! with! coma! and! a! worse! outcome.! This! IL1!
balance!was! also! associated!with! coma! and! outcome! in! the! cohort! of! patients!
with! encephalitis! overall.! IL10! was! also! inversely! associated! with! BBB!
permeability.!In!addition,!cellular!adhesion!molecules!and!CCL2!demonstrated!a!
positive! correlation!with!BBB!permeability! in! clinical! samples,! and,! along!with!
other! mediators,! in! the! HSV! infected! BBB! model! also.! These! may! represent!






































































































































































































































































































































































































10.4 Future directions 
!
!
Improved!understanding!of!the!epidemiology!of!acute!viral!encephalitis!is!
paramount!to!conducting!future!research,!to!developing!interventions!to!
improve!diagnostic!methods!and!assessing!access!to!therapeutic!options.!!!Novel!
approaches!which!access!user!data!that!may!better!reflect!the!wider!practice!of!
clinicians!may!address!some!of!these!concerns!and!have!the!advantages!of!realQ
time!capability.!However,!these!need!to!be!validated!in!parallel!prospective!
population!studies,!with!direct!comparisons!between!these!novel!technologies,!
routine!surveillance!systems,!and!targeted!case!identification!for!prospective!
studies.!!
!
Simple!interventions!such!as!a!LP!pack,!can!increase!the!proportion!of!patients!
having!the!appropriate!samples!taken!and!may!increase!the!proportion!in!whom!
a!pathogen!can!be!identified.!!However,!this!study!was!only!conducted!at!one!
centre!and!these!interventions!need!to!be!evaluated!in!multiQcentre!studies.!
Indeed!both!ClickClinica!and!the!LP!pack!are!currently!being!trialled!in!a!NIHRQ
funded!cluster!intervention!trial!(EncephQUK!2014).!This!is!assessing!these!
interventions!as!part!of!a!clinical!package!in!terms!of!the!impact!on!the!
proportion!of!patients!managed!appropriately!in!accordance!with!the!guidelines.!
The!primary!outcome!measures!being!assessed!are!the!proportion!receiving!
intravenous!acyclovir!within!6!hours!and!the!proportion!having!a!LP!within!12!
hours;!the!secondary!outcome!measures!are!the!proportion!having!a!paired!
plasma!glucose!collected!with!the!CSF!and!the!proportion!having!CSF!PCR!for!
HSV.!!In!addition!this!provides!a!valuable!opportunity!to!assess!the!cases!
 239 
identified!through!ClickClinica!in!comparison!to!those!identified!through!routine!
disease!notifications!to!Public!Health!England,!and!those!identified!through!the!
standard!approaches!of!laboratoryQdirected!screening!of!clinical!notes!as!
employed!previously!(Kelly!et!al!2012).!
!
This!study!identified!a!potential!role!for!MPO!as!identifying!patients!with!an!
infectious!aetiology.!Nevertheless,!the!routine!CSF!parameters!of!white!cell!count!
and!differential,!when!used!in!combination!with!the!CSF!protein!and!glucose!
ratio!results!can!go!a!long!way!to!determining!the!likely!aetiological!category!
(Tunkel!et!al!2008;!Kneen!et!al!2012;!Solomon!et!al!2012).!Therefore,!
prospective!blinded!studies!of!patients!with!suspected!encephalitis!are!needed!
comparing!the!CSF!and!serum!neutrophil!counts!and!MPO!concentrations!with!
the!routine!CSF!parameters!to!determine!the!relative!sensitivity,!specificity,!and!
positive!and!negative!predictive!values!of!these!approaches.!In!addition,!when!
considering!pathogenQidentification!studies,!such!as!using!nextQgeneration!
sequencing!or!proteomic!approaches,!the!CSF!cytokine!profiles!may!represent!a!
method!by!which!patients!could!be!selected!as!‘likely!infectious’,!for!example!
those!with!higher!MPO!concentrations!or!detectable!neutrophils!within!the!CSF.!
!
This!study!also!identified!a!potential!role!for!antagonism!of!IL1!in!improving!
disease!severity!and!outcome!in!HSV!encephalitis,!in!part!through!BBB!
permeability.!The!IL1!antagonists,!IL1RA!and!IL10,!should!be!applied!in!a!BBB!
model!of!HSV!infection;!and!these!should!be!assessed!with!both!luminal!and!
abluminal!administration!as!a!proxy!for!whether!intrathecal!or!intravenous!
administration!would!be!required.!In!addition,!cytometric!bead!array!should!be!
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performed!on!samples!within!this!model!to!assess!the!downQstream!effects!of!IL1!
antagonism.!Also!the!HSV!viral!load!should!be!assessed!by!realQtime!PCR!to!
assess!whether!IL1!antagonism!results!in!greater!viral!loads.!The!impact!should!
be!assessed!as!an!adjunct!to!acyclovir!therapy.!There,!is!also!the!potential!that!
the!adhesion!molecules!VCAM!and!ICAM,!and!the!chemokine!CCL2!may!be!
associated!with!increasing!permeability!and!antagonism!of!these!mediators!
should!also!be!investigated.!Targeted!antagonism!of!these!mediators!has!the!
potential!to!decrease!BBB!permeability!with!a!lesser!risk!of!increasing!the!viral!
load,!as!compared!to!broader!spectrum!immunosuppression!with!direct!
antagonism!of!IL1,!or!even!more!broadly!through!immunosuppression!with!
steroids.!!!This!work!will!need!to!be!taken!forward!in!a!murine!model!of!HSV!
encephalitis!to!assess!the!impact!of!intraQperitoneal!injection!on!markers!of!
disease!severity,!proQinflammatory!downstream!cytokine!profiles,!and!cerebral!
oedema.!These!studies!will!also!need!to!assess!whether!the!administration!of!
these!adjuncts!results!in!an!increase!in!the!viral!load.!!A!randomised!controlled!
trial!of!adjunctive!dexamethasone!is!being!undertaken!in!the!UK!with!the!
primary!outcome!being!language!function!after!discharge!(Defres!et!al!2014).!
Future!studies!will!need!to!assess!whether!there!is!any!additional!advantage!for!
targeted!proQinflammatory!blockade!with!IL1!antagonists!and/or!targeted!BBB!
permeability!therapy!with!VCAM/ICAM/CCL2!blockade,!over!simply!the!
adjunctive!use!of!dexamethasone.!
!
!
!
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